These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15032679)

  • 1. Small molecule antagonists of the tachykinin NK 2 receptor.
    Fattori D; Altamura M; Maggi CA
    Mini Rev Med Chem; 2004 Mar; 4(3):331-40. PubMed ID: 15032679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
    Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
    Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin receptor antagonism: a patent review (2014-present).
    Muñoz M; Coveñas R
    Expert Opin Ther Pat; 2020 Jul; 30(7):527-539. PubMed ID: 32401556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional regulation of human colonic smooth muscle contractility by tachykinin NK(2) receptors.
    Nakamura A; Tanaka T; Imanishi A; Kawamoto M; Toyoda M; Mizojiri G; Tsukimi Y
    J Pharmacol Sci; 2011; 117(2):106-15. PubMed ID: 21946672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
    Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
    Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and SAR of tachykinin antagonists: modulation of balance in NK(1)/NK(2) receptor antagonist activity.
    Albert JS; Aharony D; Andisik D; Barthlow H; Bernstein PR; Bialecki RA; Dedinas R; Dembofsky BT; Hill D; Kirkland K; Koether GM; Kosmider BJ; Ohnmacht C; Palmer W; Potts W; Rumsey W; Shen L; Shenvi A; Sherwood S; Warwick PJ; Russell K
    J Med Chem; 2002 Aug; 45(18):3972-83. PubMed ID: 12190319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphenyl derivatives as novel dual NK(1)/NK(2)-receptor antagonists.
    Mah R; Gerspacher M; von Sprecher A; Stutz S; Tschinke V; Anderson GP; Bertrand C; Subramanian N; Ball HA
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2065-8. PubMed ID: 12127505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
    Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinin NK2 receptor antagonists. A patent review (2006 - 2010).
    Altamura M
    Expert Opin Ther Pat; 2012 Jan; 22(1):57-77. PubMed ID: 22149761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachykinin NK-1 and NK-2 receptors in the circular muscle of the guinea-pig proximal colon.
    Santicioli P; Giuliani S; Bartho L; Maggi CA
    Regul Pept; 1993 Jul; 46(1-2):386-8. PubMed ID: 7692544
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and in vitro activities of NK-1 antagonists derived from L-tryptophan.
    Caliendo G; Fiorino F; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Albrizio S
    Farmaco; 1997 Oct; 52(10):589-93. PubMed ID: 9507670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases.
    Lecci A; Maggi CA
    Expert Opin Ther Targets; 2003 Jun; 7(3):343-62. PubMed ID: 12783571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation on C- and N-terminal moieties of a series of potent and selective linear tachykinin NK(2) receptor antagonists.
    Gensini M; Altamura M; Dimoulas T; Fedi V; Giannotti D; Giuliani S; Guidi A; Harmat NJ; Meini S; Nannicini R; Pasqui F; Tramontana M; Triolo A; Maggi CA
    ChemMedChem; 2010 Jan; 5(1):65-78. PubMed ID: 19957262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
    Mazzone SB; Geraghty DP
    Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.
    Choppin A; Groke G; Bringas A; Stepan G; Dillon MP
    Pharmacology; 2002 May; 65(2):96-102. PubMed ID: 11937780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent cyclic pseudopeptide human tachykinin NK-2 receptor antagonists.
    Giannotti D; Perrotta E; Di Bugno C; Nannicini R; Harmat NJ; Giolitti A; Patacchini R; Renzetti AR; Rotondaro L; Giuliani S; Altamura M; Maggi CA
    J Med Chem; 2000 Nov; 43(22):4041-4. PubMed ID: 11063600
    [No Abstract]   [Full Text] [Related]  

  • 17. Smooth muscle neurokinin-2 receptors mediate contraction in human saphenous veins.
    Mechiche H; Grassin-Delyle S; Pinto FM; Buenestado A; Candenas L; Devillier P
    Pharmacol Res; 2011 May; 63(5):414-22. PubMed ID: 21272642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives.
    Millet R; Domarkas J; Rigo B; Goossens L; Goossens JF; Houssin R; Hénichart JP
    Bioorg Med Chem; 2002 Sep; 10(9):2905-12. PubMed ID: 12110311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231.
    Bigioni M; Benzo A; Irrissuto C; Maggi CA; Goso C
    Anticancer Drugs; 2005 Nov; 16(10):1083-9. PubMed ID: 16222150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M
    Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.